secwatch.observer — SEC 8-K summary
======================================

Issuer:     XCel Brands, Inc. (XELB)
CIK:        0001083220
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001558370-24-005378
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xcel Brands reports FY2023 net loss $21.1M, receives Nasdaq bid price deficiency notice
--------------------------------------------------------------------------------

- GAAP net loss $21.1M for FY2023 vs $4.0M prior year (included $20.6M gain on Isaac Mizrahi sale).
- Q4 net revenue $2.3M, down 44% YoY; Adjusted EBITDA improved to -$1.2M from -$5.9M.
- Received Nasdaq deficiency letter for bid price below $1.00; 180-day cure period until Oct 14, 2024.
- Restructuring complete: reduced salaries/opex by $14M, entered new licensing for Halston, Judith Ripka, etc.
- Closed $5M term loan in Q4 2023; cash $3.0M, equity $48M at year-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083220/000155837024005378/0001558370-24-005378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083220/000155837024005378/xelb-20240416x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-005378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer